acetyl coenzyme a has been researched along with Adenocarcinoma of Lung in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lau, ATY; Mo, HY; Wei, QY; Xu, Q; Xu, YM; Yu, FY; Zhao, XY; Zhong, QH | 1 |
| Cai, Y; Chen, WL; Deng, H; Dong, C; Ge, GB; Jin, Q; Jin, X; Liu, D; Liu, L; Liu, W; Qi, SL; Qin, J; Wang, C; Wang, F; Wang, MS; Wang, S; Wang, Z; Wu, J; Xu, Z; Xue, YW; Yang, J; Yang, L; Yang, X; Yu, G; Zhang, C | 1 |
2 other study(ies) available for acetyl coenzyme a and Adenocarcinoma of Lung
| Article | Year |
|---|---|
ACC2 is under-expressed in lung adenocarcinoma and predicts poor clinical outcomes.
Topics: Acetyl Coenzyme A; Acetyl-CoA Carboxylase; Adenocarcinoma of Lung; Fatty Acids; Humans; Lung Neoplasms | 2022 |
Active post-transcriptional regulation and ACLY-mediated acetyl-CoA synthesis as a pivotal target of Shuang-Huang-Sheng-Bai formula for lung adenocarcinoma treatment.
Topics: Acetyl Coenzyme A; Adenocarcinoma of Lung; Animals; ATP Citrate (pro-S)-Lyase; Drugs, Chinese Herbal; Humans; Lung Neoplasms; Mice | 2023 |